Day: July 2, 2024

Company reaffirms commitment to community involvement, local investment, and leadership in ESG and sustainability initiatives BELVIDERE, NJ, July 02, 2024 (GLOBE NEWSWIRE) — Edible Garden AG Incorporated (“Edible Garden” or the “Company”) (Nasdaq: EDBL, EDBLW), a leader in controlled environment agriculture (CEA), locally grown, organic, and sustainable produce and products, today announced the Company has instituted a comprehensive training program in conjunction with Abilities of Northwest Jersey Inc. Established in October 1974, Abilities of Northwest Jersey is a not-for-profit 501(c)(3) agency dedicated to providing comprehensive, community-integrated employment and day services for individuals with disabilities. Over the years, Abilities has significantly broadened its offerings to better meet the diverse needs of the people...

The ceremony will be held in celebration of Scilex’s launch of GLOPERBA®, an innovative non-opioid product and the first oral liquid medicine for prophylactic treatment of painful gout flares.PALO ALTO, Calif., July 02, 2024 (GLOBE NEWSWIRE) — Scilex Holding Company (Nasdaq: SCLX, “Scilex” or the “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain, today announced that its Chief Executive Officer and President, Jaisim Shah, and Executive Chairman, Henry Ji, Ph.D., will ring the Closing Bell at the Nasdaq MarketSite in Times Square, New York, at 4:00 p.m. Eastern Time on Friday, July 5, 2024. The ceremony will be held in celebration of Scilex’s launch of GLOPERBA®, an innovative non-opioid product...

New York, NY, July 02, 2024 (GLOBE NEWSWIRE) — Bion Environmental Technologies, Inc. (OTC QB: BNET), a leader in advanced livestock waste treatment technology and sustainable livestock production, announced the appointments of Turk Stovall and Bob Weerts to its Board of Directors. Bion previously announced that Turk Stovall would be joining Bion’s Board, in addition to assuming leadership of the JV between Bion and Stovall Ranching Companies to develop a new-generation cattle feeding facility in Shepherd, Montana. Also appointed to the Board was Bob Weerts, a successful Minnesota business operator and Bion shareholder since 2020. Turk is a fifth-generation Montana rancher and CEO/owner of Stovall Ranching Companies and Yellowstone Cattle Feeders. He held management positions with Certified Angus Beef, the largest branded beef company...

Revenue Booked in Quarter Ending June 30, 2024Eco Auto is Mullen’s authorized commercial dealer for the New England AreaEco’s first commercial sale is going to a Massachusetts-based company offering custom home building, home renovations and maintenance, property management and painting services.Eco Auto’s first commercial EV sale going to a Massachusetts-based company offering custom home building, home renovations and maintenance, property management and painting services BREA, Calif., July 02, 2024 (GLOBE NEWSWIRE) — via IBN — Mullen Automotive, Inc. (NASDAQ: MULN) (“Mullen” or the “Company”), an electric vehicle (“EV”) manufacturer, announces today the first sale of its Mullen Commercial electric vehicles in Massachusetts through its new dealer partner, Eco Auto. The initial delivery will go to a Massachusetts-based...

BASSETT, Va., July 02, 2024 (GLOBE NEWSWIRE) — Bassett Furniture Industries, Inc. (Nasdaq: BSET) today announced it will host a conference call with management on Thursday, July 11, 2024, at 9:00 a.m. ET to discuss its second quarter 2024 financial results. The Company will issue its earnings release after the market closes on Wednesday, July 10, 2024. Chairman and Chief Executive Officer Rob Spilman will host the call, along with Chief Financial Officer Mike Daniel. The public is invited to listen to the conference call by webcast, accessible through the Company’s investor relations website, https://investors.bassettfurniture.com, or they can listen to the conference call via https://edge.media-server.com/mmc/p/332ii2e5. The conference call will be archived for replay on the Company’s investor site. About Bassett Furniture Industries,...

Fan-Favorite Cheetos and Pretzelmaker Pretzel Bites Combine for Ultimate Snack LOS ANGELES, July 02, 2024 (GLOBE NEWSWIRE) — Pretzelmaker, the innovator of soft Pretzel Bites and owned by FAT Brands Inc., today announces its latest ridiculously flavorful Pretzel Bite creation – Cheetos® Pretzel Bites. Made with a tantalizing dusting of Cheetos’ fan-favorite Cheetle – the new Pretzelmaker Cheetos Pretzel Bites, fresh-baked and hand-rolled daily, pair perfectly with the chain’s fresh-squeezed, all-natural Strawberry Lemonade. The new product will be available for a limited time only – now through Sept. 29, and is the latest example of Pretzelmaker’s commitment to menu innovation with the intent of bringing their customers the freshest flavors, time after time. “Similar to our partners at Cheetos, we are always striving for innovative...

Inhibition of FABP5 Demonstrates Activity in Cancer, Psoriasis, and Anxiety Disorders Results from Several Research Studies Presented at the Annual ICRS Symposium SOLANA BEACH, Calif., July 02, 2024 (GLOBE NEWSWIRE) — Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, dermatologic and neurological conditions, today announced that George Warren, Ph.D., Principal Scientist at Artelo, Myles Osborn, Medicinal Chemist at Artelo, and Matthew Jones, Ph.D. candidate from the Laviolette laboratory at the University of Western Ontario, Canada, each presented results from research studies demonstrating the broad therapeutic potential of Fatty Acid Binding Protein 5 (FABP5) inhibition at the 34th Annual International...

Drones performed optimally over three days at Fort Irwin in the Mojave Desert WICHITA, Kan., July 02, 2024 (GLOBE NEWSWIRE) — AgEagle Aerial Systems Inc. (NYSE American: UAVS) (“AgEagle” or the “Company”), an ​industry-leading​ provider of best-in-class full stack flight hardware, sensors and software for commercial and government use, announced it recently completed a training exhibition for the Opposition Forces unit at the National Training Center (NTC) at Fort Irwin, California in the Mojave Desert. Bill Irby, CEO of AgEagle, commented, “The extreme heat of the Mojave Desert presents a very challenging environment for electronic platforms to operate successfully. As expected, our eBee VISION and eBee TAC units performed with no issues over three days and were able to conduct multiple Beyond Visual Line of Sight (BLVOS) flights...

SARASOTA, Fla., July 02, 2024 (GLOBE NEWSWIRE) — Trump Media & Technology Group Corp. (NASDAQ: DJT) (“TMTG” or the “Company”)—operator of the Truth Social platform, yet another of President Donald J. Trump’s iconic American brands—today announced that the cash exercise of warrants between June 20 and July 1, 2024, has resulted in more than $105 million in cumulative proceeds. Additionally, approximately $41 million of restricted cash has recently become unrestricted. As a result, the Company had more than $350 million in cash—and no debt—on its balance sheet as of July 1, 2024. About TMTG The mission of Trump Media & Technology Group (TMTG) is to end Big Tech’s assault on free speech by opening up the Internet and giving people their voices back. TMTG operates Truth Social, a social media platform established as...

Positive topline results demonstrate clinical similarity between AVT03 and the reference biologic, Prolia® (denosumab)Two additional studies comparing the pharmacokinetics, safety, and tolerability of AVT03 to Prolia and Xgeva, respectively, have also met their primary endpointAlvotech expects to file marketing applications for AVT03 later this year for major global marketsREYKJAVIK, Iceland, July 02, 2024 (GLOBE NEWSWIRE) — Alvotech (NASDAQ: ALVO), a global biotech company specialized in the development and manufacture of biosimilar medicines for patients worldwide, announced today positive topline results from a confirmatory patient study for AVT03, a proposed biosimilar to Prolia® (denosumab) and Xgeva® (denosumab). The study met its primary endpoints. The objective of the study is to demonstrate clinical similarity...